Johnson & Johnson
JNJ
$190.85
-$0.05-0.03%
NYSE
| 06/29/2025 | 03/30/2025 | 12/29/2024 | 09/29/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.68% | 4.30% | 4.30% | 4.77% | 5.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.68% | 4.30% | 4.30% | 4.77% | 5.13% |
| Cost of Revenue | 8.61% | 7.42% | 4.61% | 4.84% | 4.21% |
| Gross Profit | 2.97% | 2.95% | 4.16% | 4.74% | 5.54% |
| SG&A Expenses | 4.87% | 5.47% | 8.16% | 7.64% | 9.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.62% | 7.76% | 8.16% | 8.14% | 5.90% |
| Operating Income | -5.46% | -4.68% | -5.57% | -3.50% | 3.21% |
| Income Before Tax | 40.21% | 32.60% | 10.79% | 25.22% | 39.01% |
| Income Tax Expenses | 50.05% | 60.28% | 50.98% | 72.75% | 94.10% |
| Earnings from Continuing Operations | 38.33% | 27.75% | 5.55% | 18.89% | 31.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -100.37% | 3,323.42% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.39% | -43.32% | -59.99% | -57.59% | 191.24% |
| EBIT | -5.46% | -4.68% | -5.57% | -3.50% | 3.21% |
| EBITDA | -2.42% | -2.78% | -3.53% | -2.32% | 3.36% |
| EPS Basic | -37.64% | -40.12% | -57.54% | -56.82% | 201.67% |
| Normalized Basic EPS | -3.52% | 1.41% | 2.56% | 12.12% | 19.22% |
| EPS Diluted | -37.40% | -39.94% | -57.43% | -56.62% | 203.01% |
| Normalized Diluted EPS | -3.40% | 1.62% | 2.46% | 12.33% | 19.43% |
| Average Basic Shares Outstanding | -4.52% | -6.29% | -8.04% | -3.51% | -3.37% |
| Average Diluted Shares Outstanding | -4.63% | -6.47% | -7.97% | -3.81% | -3.67% |
| Dividend Per Share | 4.37% | 4.20% | 4.47% | 4.74% | 5.02% |
| Payout Ratio | 1.33% | 1.39% | 2.32% | 2.07% | -0.75% |